CoChat
Sign Up
Cited by 272

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Oral Microbiome: A Review of Its Impact on Oral and Systemic Health

Rajasekaran, John J., Krishnamurthy, Hari Krishnan, Bosco, Jophi, Jayaraman, Vasanth, Krishna, Karthik, Wang, Tianhao, Bei, Kang·2024·Microorganisms
DOI 10.3390/microorganisms12091797PMC PMC11434369
Open this paper in CoChat — free account

Abstract

Purpose of review: This review investigates the oral microbiome’s composition, functions, influencing factors, connections to oral and systemic diseases, and personalized oral care strategies. Recent findings: The oral microbiome is a complex ecosystem consisting of bacteria, fungi, archaea, and viruses that contribute to oral health. Various factors, such as diet, smoking, alcohol consumption, lifestyle choices, and medical conditions, can affect the balance of the oral microbiome and lead to dysbiosis, which can result in oral health issues like dental caries, gingivitis, periodontitis, oral candidiasis, and halitosis. Importantly, our review explores novel associations between the oral microbiome and systemic diseases including gastrointestinal, cardiovascular, endocrinal, and neurological conditions, autoimmune diseases, and cancer. We comprehensively review the efficacy of interventions like dental probiotics, xylitol, oral rinses, fluoride, essential oils, oil pulling, and peptides in promoting oral health by modulating the oral microbiome. Summary: This review emphasizes the critical functions of the oral microbiota in dental and overall health, providing insights into the effects of microbial imbalances on various diseases. It underlines the significant connection between the oral microbiota and general health. Furthermore, it explores the advantages of probiotics and other dental care ingredients in promoting oral health and addressing common oral issues, offering a comprehensive strategy for personalized oral care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/microorganisms12091797

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Oral–Gut pathways to IBD and systemic diseases: Oral microbes such as Porphyromonas gingivalis can take two distinct routes to enter the body. The first is the hematogenous route (shown on the left), often associated with dental problems like tooth decay, periodontitis, gingivitis, oral thrush, and halitosis, which can further lead to systemic conditions such as CVD, neurological disorders, autoimmune diseases, diabetes, IBD, and cancer. On the other hand, the enteral route (shown in the right) allows these oral microbes to travel from the stomach to the intestines. P. gingivalis, which possesses resistance to antibiotics and can survive stomach acid, moves from the stomach into the gut. Changes in gastric acidity can alter the gut microbiota, making it resemble the oral microbiome. Upon entering the gastrointestinal tract, P. gingivalis disrupts the intestinal barrier, compromising gut integrity. This disruption, along with changes in the microbiome, initiates inflammation, typically occurring in the ileum. Within this inflammatory response, specific immune cells known as IL9+ CD4+ lamina propria T cells become active and produce IL-9, a cytokine that fuels immune responses and inflammation. While inflammation serves as a defense against invaders, excessive or chronic inflammation can lead to conditions like IBD. Abbreviations: IL-9: Interleukin-9; IL9+ CD4+ lamina propria T cells: immune cells producing IL-9; IBD: inflammatory bowel disease.
Figure 1 Oral–Gut pathways to IBD and systemic diseases: Oral microbes such as Porphyromonas gingivalis can take two distinct routes to enter the body. The first is the hematogenous route (shown on the left), often associated with dental problems like tooth decay, periodontitis, gingivitis, oral thrush, and halitosis, which can further lead to systemic conditions such as CVD, neurological disorders, autoimmune diseases, diabetes, IBD, and cancer. On the other hand, the enteral route (shown in the right) allows these oral microbes to travel from the stomach to the intestines. P. gingivalis, which possesses resistance to antibiotics and can survive stomach acid, moves from the stomach into the gut. Changes in gastric acidity can alter the gut microbiota, making it resemble the oral microbiome. Upon entering the gastrointestinal tract, P. gingivalis disrupts the intestinal barrier, compromising gut integrity. This disruption, along with changes in the microbiome, initiates inflammation, typically occurring in the ileum. Within this inflammatory response, specific immune cells known as IL9+ CD4+ lamina propria T cells become active and produce IL-9, a cytokine that fuels immune responses and inflammation. While inflammation serves as a defense against invaders, excessive or chronic inflammation can lead to conditions like IBD. Abbreviations: IL-9: Interleukin-9; IL9+ CD4+ lamina propria T cells: immune cells producing IL-9; IBD: inflammatory bowel disease.CC BY · PubMed Central
Figure 2 Mechanisms of Candida albicans pathogenicity. (A) Adhesion to host surfaces: Candida albicans initially adheres to host surfaces through weak and reversible interactions influenced by hydrophobic and electrostatic forces, facilitated by host tissue receptor glycoproteins ALS and HWP1. (B) Phenotypic switch: C. albicans can phenotypically switch between yeast and hyphal states. (C) Host cell receptor interaction: C. albicans can adhere to epithelial cells using various host cell receptors, such as EphA2 (through β-glucan) and E-cadherin (through ALS3). Host cell transglutaminases create a cross-linking between C. albicans and the epithelial surface by interacting with HWP1. (D) Biofilm formation: Interaction with oral bacteria, such as Streptococcus gordonii, promotes the formation of biofilms. ALS3 on C. albicans binds to surface protein SspB on S. gordonii, facilitating biofilm formation. (E) Hyphal penetration into epithelial cells: The shift to the hyphal form is crucial for tissue invasion. Hyphae infiltrate and harm epithelial cells, causing inflammation and white patches in oral thrush. Abbreviations: ALS: agglutinin-like sequence; HWP1: hyphal wall protein; SspB: surface protein SspB; EphA2: Eph receptor A2.
Figure 2 Mechanisms of Candida albicans pathogenicity. (A) Adhesion to host surfaces: Candida albicans initially adheres to host surfaces through weak and reversible interactions influenced by hydrophobic and electrostatic forces, facilitated by host tissue receptor glycoproteins ALS and HWP1. (B) Phenotypic switch: C. albicans can phenotypically switch between yeast and hyphal states. (C) Host cell receptor interaction: C. albicans can adhere to epithelial cells using various host cell receptors, such as EphA2 (through β-glucan) and E-cadherin (through ALS3). Host cell transglutaminases create a cross-linking between C. albicans and the epithelial surface by interacting with HWP1. (D) Biofilm formation: Interaction with oral bacteria, such as Streptococcus gordonii, promotes the formation of biofilms. ALS3 on C. albicans binds to surface protein SspB on S. gordonii, facilitating biofilm formation. (E) Hyphal penetration into epithelial cells: The shift to the hyphal form is crucial for tissue invasion. Hyphae infiltrate and harm epithelial cells, causing inflammation and white patches in oral thrush. Abbreviations: ALS: agglutinin-like sequence; HWP1: hyphal wall protein; SspB: surface protein SspB; EphA2: Eph receptor A2.CC BY · PubMed Central
Figure 3 Mechanisms linking oral pathogens to RA. Porphyromonas gingivalis and RA link: P. gingivalis possesses virulent factors, including the PPAD, which citrullinates host proteins. This citrullination is thought to trigger autoimmune responses, leading to the production of ACPAs characteristic of RA. NETs and ACPA production: NETs formed during periodontitis contribute to protein citrullination catalyzed by PAD4 enzymes, further enhancing ACPA production. Aggregatibacter actinomycetemcomitans and RA: A. actinomycetemcomitans secretes LtxA, triggering neutrophil hypercitrullination and the release of citrullinated autoantigens, further fueling the ACPA response. Citrullinated autoantigens can trigger an autoimmune response, wherein Th17 cells in the immune system become overactivated. Th17 cells are known for producing pro-inflammatory cytokines, notably IL-17. IL-17 stimulates B cells to produce antibodies, including ACPAs. These antibodies can target citrullinated proteins, contributing to the autoimmune processes and inflammation seen in RA. Abbreviations: PPAD: protein arginine deiminase of P. gingivalis; ACPAs: anticitrullinated protein antibodies; PAD4: peptidylarginine deiminase 4; LtxA: leukotoxin A; Th17: T helper 17; IL 17: interleukin-17; RA: rheumatoid arthritis.
Figure 3 Mechanisms linking oral pathogens to RA. Porphyromonas gingivalis and RA link: P. gingivalis possesses virulent factors, including the PPAD, which citrullinates host proteins. This citrullination is thought to trigger autoimmune responses, leading to the production of ACPAs characteristic of RA. NETs and ACPA production: NETs formed during periodontitis contribute to protein citrullination catalyzed by PAD4 enzymes, further enhancing ACPA production. Aggregatibacter actinomycetemcomitans and RA: A. actinomycetemcomitans secretes LtxA, triggering neutrophil hypercitrullination and the release of citrullinated autoantigens, further fueling the ACPA response. Citrullinated autoantigens can trigger an autoimmune response, wherein Th17 cells in the immune system become overactivated. Th17 cells are known for producing pro-inflammatory cytokines, notably IL-17. IL-17 stimulates B cells to produce antibodies, including ACPAs. These antibodies can target citrullinated proteins, contributing to the autoimmune processes and inflammation seen in RA. Abbreviations: PPAD: protein arginine deiminase of P. gingivalis; ACPAs: anticitrullinated protein antibodies; PAD4: peptidylarginine deiminase 4; LtxA: leukotoxin A; Th17: T helper 17; IL 17: interleukin-17; RA: rheumatoid arthritis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 244

  1. Wade, 2013, The oral microbiome in health and disease, Pharmacol. Res., 69, 137, 10.1016/j.phrs.2012.11.006 · DOI · Paper page
  2. Forshaw, 2009, Dental health and disease in ancient Egypt, Br. Dent. J., 206, 421, 10.1038/sj.bdj.2009.309 · DOI
  3. Alam, 2022, Metabolism and Health Impacts of Dietary Sugars, J. Lipid Atheroscler., 11, 20, 10.12997/jla.2022.11.1.20 · DOI
  4. Zarco, 2012, The oral microbiome in health and disease and the potential impact on personalized dental medicine, Oral Dis., 18, 109, 10.1111/j.1601-0825.2011.01851.x · DOI
  5. He, 2015, The oral microbiome diversity and its relation to human diseases, Folia Microbiol., 60, 69, 10.1007/s12223-014-0342-2 · DOI · Paper page
  6. Thomas, C., Minty, M., Vinel, A., Canceill, T., Loubières, P., Burcelin, R., Kaddech, M., Blasco-Baque, V., and Laurencin-Dalicieux, S. (2021). Oral Microbiota: A Major Player in the Diagnosis of Systemic Diseases. Diagnostics, 11. · DOI
  7. Lee, Y.-H., Chung, S.W., Auh, Q.-S., Hong, S.-J., Lee, Y.-A., Jung, J., Lee, G.-J., Park, H.J., Shin, S.-I., and Hong, J.-Y. (2021). Progress in Oral Microbiome Related to Oral and Systemic Diseases: An Update. Diagnostics, 11. · DOI
  8. Malla, M.A., Dubey, A., Kumar, A., Yadav, S., Hashem, A., and Abd Allah, E.F. (2019). Exploring the Human Microbiome: The Potential Future Role of Next-Generation Sequencing in Disease Diagnosis and Treatment. Front. Immunol., 9. · DOI
  9. Pozhitkov, 2011, High-throughput methods for analysis of the human oral microbiome, Periodontology 2000, 55, 70, 10.1111/j.1600-0757.2010.00380.x · DOI
  10. Alcaraz, 2012, Identifying a healthy oral microbiome through metagenomics, Clin. Microbiol. Infect., 18, 54, 10.1111/j.1469-0691.2012.03857.x · DOI
  11. Willis, J.R., and Gabaldón, T. (2020). The Human Oral Microbiome in Health and Disease: From Sequences to Ecosystems. Microorganisms, 8. · DOI
  12. Zhang, 2021, Using next-generation sequencing to detect oral microbiome change following periodontal interventions: A systematic review, Oral Dis., 27, 1073, 10.1111/odi.13405 · DOI
  13. Lazarevic, 2009, Metagenomic study of the oral microbiota by Illumina high-throughput sequencing, J. Microbiol. Methods, 79, 266, 10.1016/j.mimet.2009.09.012 · DOI
  14. Jeong, J., Mun, S., Oh, Y., Cho, C.-S., Yun, K., Ahn, Y., Chung, W.-H., Lim, M.Y., Lee, K.E., and Hwang, T.S. (2022). A qRT-PCR Method Capable of Quantifying Specific Microorganisms Compared to NGS-Based Metagenome Profiling Data. Microorganisms, 10. · DOI
  15. Jung, J.Y., Yoon, H.K., An, S., Lee, J.W., Ahn, E.-R., Kim, Y.-J., Park, H.-C., Lee, K., Hwang, J.H., and Lim, S.-K. (2018). Rapid oral bacteria detection based on real-time PCR for the forensic identification of saliva. Sci. Rep., 8. · DOI
  16. Lochman, J., Zapletalova, M., Poskerova, H., Izakovicova Holla, L., and Borilova Linhartova, P. (2019). Rapid Multiplex Real-Time PCR Method for the Detection and Quantification of Selected Cariogenic and Periodontal Bacteria. Diagnostics, 10. · DOI
  17. Morillo, 2003, Quantitative real-time PCR based on single copy gene sequence for detection of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis, J. Periodontal Res., 38, 518, 10.1034/j.1600-0765.2003.00684.x · DOI
  18. Fan, X., Peters, B.A., Min, D., and Ahn, J. (2018). Comparison of the oral microbiome in mouthwash and whole saliva samples. PLoS ONE, 13. · DOI
  19. Jo, R., Nishimoto, Y., Umezawa, K., Yama, K., Aita, Y., Ichiba, Y., Murakami, S., Kakizawa, Y., Kumagai, T., and Yamada, T. (2019). Comparison of oral microbiome profiles in stimulated and unstimulated saliva, tongue, and mouth-rinsed water. Sci. Rep., 9. · DOI
  20. Ames, 2017, The Human Microbiome and Understanding the 16S rRNA Gene in Translational Nursing Science, Nurs. Res., 66, 184, 10.1097/NNR.0000000000000212 · DOI
  21. Sharma, 2018, Oral microbiome and health, AIMS Microbiol., 4, 42, 10.3934/microbiol.2018.1.42 · DOI
  22. Huang, 2011, Bacterial interactions in dental biofilm, Virulence, 2, 435, 10.4161/viru.2.5.16140 · DOI
  23. Burne, 1999, Genetic and Physiologic Characterization of Urease of Actinomyces naeslundii, Infect. Immun., 67, 504, 10.1128/IAI.67.2.504-512.1999 · DOI
  24. Zhang, Y., Ding, Y., and Guo, Q. (2022). Probiotic Species in the Management of Periodontal Diseases: An Overview. Front. Cell. Infect. Microbiol., 12. · DOI
  25. Marsh, 2000, Role of the Oral Microflora in Health, Microb. Ecol. Health Dis., 12, 130
  26. Bradshaw, 1998, Role of Fusobacterium nucleatum and Coaggregation in Anaerobe Survival in Planktonic and Biofilm Oral Microbial Communities during Aeration, Infect. Immun., 66, 4729, 10.1128/IAI.66.10.4729-4732.1998 · DOI
  27. Könönen, E., Fteita, D., Gursoy, U.K., and Gursoy, M. (2022). Prevotella species as oral residents and infectious agents with potential impact on systemic conditions. J. Oral Microbiol., 14. · DOI
  28. Baker, 2017, Ecology of the Oral Microbiome: Beyond Bacteria, Trends Microbiol., 25, 362, 10.1016/j.tim.2016.12.012 · DOI
  29. Diaz, 2021, Critically Appraising the Significance of the Oral Mycobiome, J. Dent. Res., 100, 133, 10.1177/0022034520956975 · DOI
  30. Krom, 2014, Candida and Other Fungal Species: Forgotten Players of Healthy Oral Microbiota, J. Dent. Res., 93, 445, 10.1177/0022034514521814 · DOI · Paper page
  31. Matarazzo, 2011, Diversity and quantitative analysis of Archaea in aggressive periodontitis and periodontally healthy subjects, J. Clin. Periodontol., 38, 621, 10.1111/j.1600-051X.2011.01734.x · DOI
  32. Lepp, 2004, Methanogenic Archaea and human periodontal disease, Proc. Natl. Acad. Sci. USA, 101, 6176, 10.1073/pnas.0308766101 · DOI
  33. Slots, 2021, The human oral phageome, Periodontology 2000, 86, 79, 10.1111/prd.12363 · DOI
  34. Liang, 2021, The human virome: Assembly, composition and host interactions, Nat. Rev. Microbiol., 19, 514, 10.1038/s41579-021-00536-5 · DOI
  35. Ly, 2014, Altered Oral Viral Ecology in Association with Periodontal Disease, mBio, 5, e01133-14, 10.1128/mBio.01133-14 · DOI
  36. Abbas, 2019, Redondoviridae, a Family of Small, Circular DNA Viruses of the Human Oro-Respiratory Tract Associated with Periodontitis and Critical Illness, Cell Host Microbe, 25, 719, 10.1016/j.chom.2019.04.001 · DOI
  37. Spezia, 2020, Redondovirus DNA in human respiratory samples, J. Clin. Virol., 131, 104586, 10.1016/j.jcv.2020.104586 · DOI
  38. Schlagenhauf, U. (2022). On the Role of Dietary Nitrate in the Maintenance of Systemic and Oral Health. Dent. J., 10. · DOI
  39. Pytko-Polończyk, J., Stawarz-Janeczek, M., Kryczyk-Poprawa, A., and Muszyńska, B. (2021). Antioxidant-Rich Natural Raw Materials in the Prevention and Treatment of Selected Oral Cavity and Periodontal Diseases. Antioxidants, 10. · DOI
  40. Jia, Y.-J., Liao, Y., He, Y.-Q., Zheng, M.-Q., Tong, X.-T., Xue, W.-Q., Zhang, J.-B., Yuan, L.-L., Zhang, W.-L., and Jia, W.-H. (2021). Association Between Oral Microbiota and Cigarette Smoking in the Chinese Population. Front. Cell. Infect. Microbiol., 11. · DOI
  41. Wagenknecht, 2018, Effects of Nicotine on Oral Microorganisms, Human Tissues, and the Interactions between Them, Curr. Oral Health Rep., 5, 78, 10.1007/s40496-018-0173-3 · DOI
  42. Beghini, 2019, Tobacco exposure associated with oral microbiota oxygen utilization in the New York City Health and Nutrition Examination Study, Ann. Epidemiol., 34, 18, 10.1016/j.annepidem.2019.03.005 · DOI
  43. Yussof, A., Yoon, P., Krkljes, C., Schweinberg, S., Cottrell, J., Chu, T., and Chang, S.L. (2020). A meta-analysis of the effect of binge drinking on the oral microbiome and its relation to Alzheimer’s disease. Sci. Rep., 10. · DOI
  44. Riedel, 2005, Alcohol-related diseases of the mouth and throat, Dig. Dis., 23, 195, 10.1159/000090166 · DOI
  45. Enberg, 2001, Saliva flow rate, amylase activity, and protein and electrolyte concentrations in saliva after acute alcohol consumption, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 92, 292, 10.1067/moe.2001.116814 · DOI
  46. Maier, 1988, Effect of chronic ethanol and nicotine consumption on the function and morphology of the salivary glands, Klin. Wochenschr., 66, 140
  47. Szabo, 1999, Consequences of Alcohol Consumption on Host Defence, Alcohol Alcohol., 34, 830, 10.1093/alcalc/34.6.830 · DOI
  48. Szabo, 1996, Regulation of human monocyte functions by acute ethanol treatment: Decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin-10, and transforming growth factor-beta production, Alcohol. Clin. Exp. Res., 20, 900, 10.1111/j.1530-0277.1996.tb05269.x · DOI
  49. Pepersack, 1992, Longitudinal study of bone metabolism after ethanol withdrawal in alcoholic patients, J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res., 7, 383, 10.1002/jbmr.5650070405 · DOI
  50. Ogden, 1999, Effect of alcohol on the oral mucosa assessed by quantitative cytomorphometry, J. Oral Pathol. Med. Off. Publ. Int. Assoc. Oral Pathol. Am. Acad. Oral Pathol., 28, 216
  51. Fan, X., Peters, B.A., Jacobs, E.J., Gapstur, S.M., Purdue, M.P., Freedman, N.D., Alekseyenko, A.V., Wu, J., Yang, L., and Pei, Z. (2018). Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults. Microbiome, 6. · DOI
  52. Barb, J.J., Maki, K.A., Kazmi, N., Meeks, B.K., Krumlauf, M., Tuason, R.T., Brooks, A.T., Ames, N.J., Goldman, D., and Wallen, G.R. (2021). The oral microbiome in alcohol use disorder: A longitudinal analysis during inpatient treatment. J. Oral Microbiol., 14. · DOI
  53. Li, X., Zhao, K., Chen, J., Ni, Z., Yu, Z., Hu, L., Qin, Y., Zhao, J., Peng, W., and Lu, L. (2022). Diurnal changes of the oral microbiome in patients with alcohol dependence. Front. Cell Infect. Microbiol., 12. · DOI
  54. Liao, Y., Tong, X.-T., Jia, Y.-J., Liu, Q.-Y., Wu, Y.-X., Xue, W.-Q., He, Y.-Q., Wang, T.-M., Zheng, X.-H., and Zheng, M.-Q. (2022). The Effects of Alcohol Drinking on Oral Microbiota in the Chinese Population. Int. J. Environ. Res. Public Health, 19. · DOI
  55. Thomas, A.M., Gleber-Netto, F.O., Fernandes, G.R., Amorim, M., Barbosa, L.F., Francisco, A.L.N., Guerra de Andrade, A., Setubal, J.C., Kowalski, L.P., and Nunes, D.N. (2014). Alcohol and tobacco consumption affects bacterial richness in oral cavity mucosa biofilms. BMC Microbiol., 14. · DOI
  56. Gm, 2021, Oral Biofilm and Its Impact on Oral Health, Psychological and Social Interaction, Int. J. Oral Dent. Health, 7, 127
  57. Peng, 2022, Oral microbiota in human systematic diseases, Int. J. Oral Sci., 14, 14, 10.1038/s41368-022-00163-7 · DOI
  58. Patangia, D.V., Anthony Ryan, C., Dempsey, E., Paul Ross, R., and Stanton, C. (2022). Impact of antibiotics on the human microbiome and consequences for host health. MicrobiologyOpen, 11. · DOI
  59. Farah, 2010, Oral fungal infections: An update for the general practitioner, Aust. Dent. J., 55, 48, 10.1111/j.1834-7819.2010.01198.x · DOI
  60. Roberts, A.P., and Kreth, J. (2014). The impact of horizontal gene transfer on the adaptive ability of the human oral microbiome. Front. Cell. Infect. Microbiol., 4. · DOI · Paper page
  61. Segata, N., Haake, S.K., Mannon, P., Lemon, K.P., Waldron, L., Gevers, D., Huttenhower, C., and Izard, J. (2012). Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol., 13. · DOI · Paper page
  62. Sovran, B., Hugenholtz, F., Elderman, M., Van Beek, A.A., Graversen, K., Huijskes, M., Boekschoten, M.V., Savelkoul, H.F.J., De Vos, P., and Dekker, J. (2019). Age-associated Impairment of the Mucus Barrier Function is Associated with Profound Changes in Microbiota and Immunity. Sci. Rep., 9. · DOI
  63. Toda, K., Hisata, K., Satoh, T., Katsumata, N., Odamaki, T., Mitsuyama, E., Katayama, T., Kuhara, T., Aisaka, K., and Shimizu, T. (2019). Neonatal oral fluid as a transmission route for bifidobacteria to the infant gut immediately after birth. Sci. Rep., 9. · DOI
  64. P744 (2016). Proton pump inhibitors affect the gut microbiome. J. Crohns Colitis, 10, S487. · DOI
  65. Park, S.-Y., Hwang, B.-O., Lim, M., Ok, S.-H., Lee, S.-K., Chun, K.-S., Park, K.-K., Hu, Y., Chung, W.-Y., and Song, N.-Y. (2021). Oral-Gut Microbiome Axis in Gastrointestinal Disease and Cancer. Cancers, 13. · DOI
  66. Khor, B., Snow, M., Herrman, E., Ray, N., Mansukhani, K., Patel, K.A., Said-Al-Naief, N., Maier, T., and Machida, C.A. (2021). Interconnections between the Oral and Gut Microbiomes: Reversal of Microbial Dysbiosis and the Balance between Systemic Health and Disease. Microorganisms, 9. · DOI
  67. Kitamoto, 2020, The Bacterial Connection between the Oral Cavity and the Gut Diseases, J. Dent. Res., 99, 1021, 10.1177/0022034520924633 · DOI
  68. Walker, 2018, Role of oral and gut microbiome in nitric oxide-mediated colon motility, Nitric Oxide Biol. Chem., 73, 81, 10.1016/j.niox.2017.06.003 · DOI
  69. Bowen, 2018, Oral Biofilms: Pathogens, Matrix and Polymicrobial Interactions in Microenvironments, Trends Microbiol., 26, 229, 10.1016/j.tim.2017.09.008 · DOI · Paper page
  70. Suwannakul, 2010, Identification of bistable populations of Porphyromonas gingivalis that differ in epithelial cell invasion, Microbiology, 156, 3052, 10.1099/mic.0.038075-0 · DOI
  71. Tanner, 2018, The Caries Microbiome: Implications for Reversing Dysbiosis, Adv. Dent. Res., 29, 78, 10.1177/0022034517736496 · DOI
  72. Selwitz, 2007, Dental caries, Lancet, 369, 51, 10.1016/S0140-6736(07)60031-2 · DOI · Paper page
  73. Takahashi, 2008, Caries Ecology Revisited: Microbial Dynamics and the Caries Process, Caries Res., 42, 409, 10.1159/000159604 · DOI
  74. Seminario, 2005, Mutans streptococci and the development of dental plaque, Prague Med. Rep., 106, 349
  75. Dombi, 2004, Effect of amine fluoride/stannous fluoride toothpaste and mouthrinse on dental plaque accumulation and gingival health, Oral Dis., 10, 294, 10.1111/j.1601-0825.2004.01025.x · DOI
  76. Chen, X., Daliri, E.B.-M., Kim, N., Kim, J.-R., Yoo, D., and Oh, D.-H. (2020). Microbial Etiology and Prevention of Dental Caries: Exploiting Natural Products to Inhibit Cariogenic Biofilms. Pathogens, 9. · DOI
  77. Zhang, Q., Nijampatnam, B., Hua, Z., Nguyen, T., Zou, J., Cai, X., Michalek, S.M., Velu, S.E., and Wu, H. (2017). Structure-Based Discovery of Small Molecule Inhibitors of Cariogenic Virulence. Sci. Rep., 7. · DOI
  78. Simón-Soro, A., Guillen-Navarro, M., and Mira, A. (2014). Metatranscriptomics reveals overall active bacterial composition in caries lesions. J. Oral Microbiol., 6. · DOI
  79. Mira, 2015, Solving the etiology of dental caries, Trends Microbiol., 23, 76, 10.1016/j.tim.2014.10.010 · DOI
  80. Gross, E.L., Beall, C.J., Kutsch, S.R., Firestone, N.D., Leys, E.J., and Griffen, A.L. (2012). Beyond Streptococcus mutans: Dental Caries Onset Linked to Multiple Species by 16S rRNA Community Analysis. PLoS ONE, 7. · DOI
  81. Mantzourani, 2009, Association between Bifidobacteriaceae and the clinical severity of root caries lesions, Oral Microbiol. Immunol., 24, 32, 10.1111/j.1399-302X.2008.00470.x · DOI
  82. Badet, 2008, Ecology of lactobacilli in the oral cavity: A review of literature, Open Microbiol. J., 2, 38, 10.2174/1874285800802010038 · DOI
  83. Catalan, 2013, Microbial Geography of the Oral Cavity, J. Dent. Res., 92, 616, 10.1177/0022034513488119 · DOI
  84. Farha, 2020, Inflammation of the Gums, Malays. Fam. Physician Off. J. Acad. Fam. Physicians Malays., 15, 71
  85. Rathee, M., and Jain, P. (2024, May 03). Gingivitis, StatPearls, Available online: http://www.ncbi.nlm.nih.gov/books/NBK557422/.
  86. Gao, 2018, Oral microbiomes: More and more importance in oral cavity and whole body, Protein Cell, 9, 488, 10.1007/s13238-018-0548-1 · DOI · Paper page
  87. Lu, 2019, Oral microbiota: A new view of body health, Food Sci. Hum. Wellness, 8, 8, 10.1016/j.fshw.2018.12.001 · DOI
  88. Moore, 1994, The bacteria of periodontal diseases, Periodontology 2000, 5, 66, 10.1111/j.1600-0757.1994.tb00019.x · DOI
  89. Kistler, J.O., Booth, V., Bradshaw, D.J., and Wade, W.G. (2013). Bacterial community development in experimental gingivitis. PLoS ONE, 8. · DOI
  90. Abdulkareem, A.A., Al-Taweel, F.B., Al-Sharqi, A.J.B., Gul, S.S., Sha, A., and Chapple, I.L.C. (2023). Current concepts in the pathogenesis of periodontitis: From symbiosis to dysbiosis. J. Oral Microbiol., 15. · DOI
  91. Jiao, 2014, The Role of Oral Pathobionts in Dysbiosis during Periodontitis Development, J. Dent. Res., 93, 539, 10.1177/0022034514528212 · DOI
  92. Kapoor, 2016, Halitosis: Current concepts on etiology, diagnosis and management, Eur. J. Dent., 10, 292, 10.4103/1305-7456.178294 · DOI
  93. Cortelli, 2008, Halitosis: A review of associated factors and therapeutic approach, Braz. Oral Res., 22, 44, 10.1590/S1806-83242008000500007 · DOI
  94. Hampelska, K., Jaworska, M.M., Babalska, Z.Ł., and Karpiński, T.M. (2020). The Role of Oral Microbiota in Intra-Oral Halitosis. J. Clin. Med., 9. · DOI
  95. Yang, 2013, Microbial Basis of Oral Malodor Development in Humans, J. Dent. Res., 92, 1106, 10.1177/0022034513507065 · DOI
  96. Nakano, 2002, Correlation between oral malodor and periodontal bacteria, Microbes Infect., 4, 679, 10.1016/S1286-4579(02)01586-1 · DOI
  97. Ratcliff, 1999, The Relationship Between Oral Malodor, Gingivitis, and Periodontitis. A Review, J. Periodontol., 70, 485, 10.1902/jop.1999.70.5.485 · DOI · Paper page
  98. Porter, 2006, Oral malodour (halitosis), BMJ, 333, 632, 10.1136/bmj.38954.631968.AE · DOI
  99. Persson, 1990, The formation of hydrogen sulfide and methyl mercaptan by oral bacteria, Oral Microbiol. Immunol., 5, 195, 10.1111/j.1399-302X.1990.tb00645.x · DOI
  100. Takeshita, T., Suzuki, N., Nakano, Y., Yasui, M., Yoneda, M., Shimazaki, Y., Hirofuji, T., and Yamashita, Y. (2012). Discrimination of the oral microbiota associated with high hydrogen sulfide and methyl mercaptan production. Sci. Rep., 2. · DOI
  101. Washio, 2005, Hydrogen sulfide-producing bacteria in tongue biofilm and their relationship with oral malodour, J. Med. Microbiol., 54, 889, 10.1099/jmm.0.46118-0 · DOI
  102. Solemdal, K., Sandvik, L., Willumsen, T., Mowe, M., and Hummel, T. (2012). The impact of oral health on taste ability in acutely hospitalized elderly. PLoS ONE, 7. · DOI
  103. Finkelstein, 1999, Workshop on taste and smell in the elderly: An overview, Physiol. Behav., 66, 173, 10.1016/S0031-9384(98)00261-3 · DOI
  104. Lindemann, 2001, Receptors and transduction in taste, Nature, 413, 219, 10.1038/35093032 · DOI
  105. Spielman, 1990, Interaction of saliva and taste, J. Dent. Res., 69, 838, 10.1177/00220345900690030101 · DOI
  106. Matsuo, 2000, Role of saliva in the maintenance of taste sensitivity, Crit. Rev. Oral Biol. Med., 11, 216, 10.1177/10454411000110020501 · DOI
  107. Nederfors, 1997, Prevalence of perceived symptoms of dry mouth in an adult Swedish population—Relation to age, sex and pharmacotherapy, Community Dent. Oral Epidemiol., 25, 211, 10.1111/j.1600-0528.1997.tb00928.x · DOI
  108. Kamel, 2009, Impact of primary Sjogren’s syndrome on smell and taste: Effect on quality of life, Rheumatology, 48, 1512, 10.1093/rheumatology/kep249 · DOI
  109. Weiffenbach, 1995, Taste performance in Sjogren’s syndrome, Physiol. Behav., 57, 89, 10.1016/0031-9384(94)00211-M · DOI
  110. Aravindhan, 2014, Burning mouth syndrome: A review on its diagnostic and therapeutic approach, J. Pharm. Bioallied Sci., 6, S21, 10.4103/0975-7406.137255 · DOI
  111. Lee, B.-M., Park, J.W., Jo, J.H., Oh, B., and Chung, G. (2022). Comparative analysis of the oral microbiome of burning mouth syndrome patients. J. Oral Microbiol., 14. · DOI
  112. Singh, 2014, Oral candidiasis: An overview, J. Oral Maxillofac. Pathol. JOMFP, 18, S81, 10.4103/0973-029X.141325 · DOI
  113. Muddana, 2021, Fungal Infections of Oral Cavity: Diagnosis, Management, and Association with COVID-19, SN Compr. Clin. Med., 3, 1373, 10.1007/s42399-021-00873-9 · DOI
  114. Arya, N.R., and Rafiq, N.B. (2023, September 20). Candidiasis, StatPearls, Available online: https://www.ncbi.nlm.nih.gov/books/NBK560624/.
  115. (2023, September 20). Oral Thrush: Overview, Available online: https://www.ncbi.nlm.nih.gov/books/NBK367586/.
  116. Cotter, 2000, Adherence mechanisms of Candida albicans, Br. J. Biomed. Sci., 57, 241
  117. Hoyer, 2001, The ALS gene family of Candida albicans, Trends Microbiol., 9, 176, 10.1016/S0966-842X(01)01984-9 · DOI · Paper page
  118. Hoyer, 2008, Discovering the Secrets of the Candida albicans Agglutinin-Like Sequence (ALS) Gene Family—A Sticky Pursuit, Med. Mycol., 46, 1, 10.1080/13693780701435317 · DOI · Paper page
  119. Nikou, S.-A., Kichik, N., Brown, R., Ponde, N.O., Ho, J., Naglik, J.R., and Richardson, J.P. (2019). Candida albicans Interactions with Mucosal Surfaces during Health and Disease. Pathogens, 8. · DOI · Paper page
  120. Naglik, 2006, Candida albicans HWP1 gene expression and host antibody responses in colonization and disease, J. Med. Microbiol., 55, 1323, 10.1099/jmm.0.46737-0 · DOI
  121. Sundstrom, 2002, Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice, J. Infect. Dis., 185, 521, 10.1086/338836 · DOI
  122. Silverman, 2010, Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed-species communities, Infect. Immun., 78, 4644, 10.1128/IAI.00685-10 · DOI · Paper page
  123. Lewis, 2017, Diagnosis and management of oral candidosis, Br. Dent. J., 223, 675, 10.1038/sj.bdj.2017.886 · DOI
  124. Naglik, 2003, Candida albicans secreted aspartyl proteinases in virulence and pathogenesis, Microbiol. Mol. Biol. Rev., 67, 400, 10.1128/MMBR.67.3.400-428.2003 · DOI · Paper page
  125. Mogavero, 2016, Interaction of Candida albicans with host cells: Virulence factors, host defense, escape strategies, and the microbiota, J. Microbiol., 54, 149, 10.1007/s12275-016-5514-0 · DOI
  126. Swidergall, 2019, Candidalysin Is Required for Neutrophil Recruitment and Virulence During Systemic Candida albicans Infection, J. Infect. Dis., 220, 1477, 10.1093/infdis/jiz322 · DOI
  127. Moyes, 2016, Candidalysin is a fungal peptide toxin critical for mucosal infection, Nature, 532, 64, 10.1038/nature17625 · DOI
  128. Seedorf, 2014, Bacteria from Diverse Habitats Colonize and Compete in the Mouse Gut, Cell, 159, 253, 10.1016/j.cell.2014.09.008 · DOI
  129. Schmitz, 1999, Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis, Gastroenterology, 116, 301, 10.1016/S0016-5085(99)70126-5 · DOI
  130. Peeters, 1997, Clustering of increased small intestinal permeability in families with Crohn’s disease, Gastroenterology, 113, 802, 10.1016/S0016-5085(97)70174-4 · DOI
  131. Brennan, 2019, Fusobacterium nucleatum—Symbiont, opportunist and oncobacterium, Nat Rev Microbiol., 17, 156, 10.1038/s41579-018-0129-6 · DOI · Paper page
  132. Schincaglia, 2017, Clinical, Immune, and Microbiome Traits of Gingivitis and Peri-implant Mucositis, J. Dent. Res., 96, 47, 10.1177/0022034516668847 · DOI
  133. Sohn, 2022, Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9-producing CD4+ T cells, Mol. Oral Microbiol., 37, 42, 10.1111/omi.12359 · DOI
  134. Abusleme, 2013, The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation, ISME J., 7, 1016, 10.1038/ismej.2012.174 · DOI
  135. Li, Y., Zhu, M., Liu, Y., Luo, B., Cui, J., Huang, L., Chen, K., and Liu, Y. (2022). The oral microbiota and cardiometabolic health: A comprehensive review and emerging insights. Front. Immunol., 13. · DOI
  136. Lucchese, 2017, Streptococcus mutans antigen I/II and autoimmunity in cardiovascular diseases, Autoimmun. Rev., 16, 456, 10.1016/j.autrev.2017.03.009 · DOI
  137. Xie, 2020, BMAL1-Downregulation Aggravates Porphyromonas gingivalis-Induced Atherosclerosis by Encouraging Oxidative Stress, Circ. Res., 126, e15, 10.1161/CIRCRESAHA.119.315502 · DOI
  138. Stinson, 2003, Invasion and killing of human endothelial cells by viridans group streptococci, Infect. Immun., 71, 2365, 10.1128/IAI.71.5.2365-2372.2003 · DOI
  139. Ramos, 2004, Bacterial flagellins: Mediators of pathogenicity and host immune responses in mucosa, Trends Microbiol., 12, 509, 10.1016/j.tim.2004.09.002 · DOI
  140. Zindel, 2020, DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation, Annu. Rev. Pathol., 15, 493, 10.1146/annurev-pathmechdis-012419-032847 · DOI
  141. Kaur, 2014, Aggregatibacter actinomycetemcomitans leukotoxin (LtxA, Leukothera) induces cofilin dephosphorylation and actin depolymerization during killing of malignant monocytes, Microbiology, 160, 2443, 10.1099/mic.0.082347-0 · DOI
  142. Aarabi, G., Heydecke, G., and Seedorf, U. (2018). Roles of Oral Infections in the Pathomechanism of Atherosclerosis. Int. J. Mol. Sci., 19. · DOI
  143. Chhibber-Goel, J., Singhal, V., Bhowmik, D., Vivek, R., Parakh, N., Bhargava, B., and Sharma, A. (2016). Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients. NPJ Biofilms Microbiomes, 2. · DOI
  144. Plachokova, A.S., Andreu-Sánchez, S., Noz, M.P., Fu, J., and Riksen, N.P. (2021). Oral Microbiome in Relation to Periodontitis Severity and Systemic Inflammation. Int. J. Mol. Sci., 22. · DOI
  145. Morimoto, 1993, Cells in stress: Transcriptional activation of heat shock genes, Science, 259, 1409, 10.1126/science.8451637 · DOI
  146. Goulhen, 2003, Oral microbial heat-shock proteins and their potential contributions to infections, Crit. Rev. Oral Biol. Med., 14, 399, 10.1177/154411130301400603 · DOI
  147. Xiao, 2017, Diabetes Enhances IL-17 Expression and Alters the Oral Microbiome to Increase Its Pathogenicity, Cell Host Microbe, 22, 120, 10.1016/j.chom.2017.06.014 · DOI · Paper page
  148. Mashimo, 1983, The periodontal microflora of juvenile diabetics. Culture, immunofluorescence, and serum antibody studies, J. Periodontol., 54, 420, 10.1902/jop.1983.54.7.420 · DOI
  149. Sallum, 2008, Clinical and laboratory evaluations of non-surgical periodontal treatment in subjects with diabetes mellitus, J. Periodontol., 79, 1150, 10.1902/jop.2008.070503 · DOI
  150. Campus, 2005, Diabetes and periodontal disease: A case-control study, J. Periodontol., 76, 418, 10.1902/jop.2005.76.3.418 · DOI
  151. Graves, 2019, The Oral Microbiota Is Modified by Systemic Diseases, J. Dent. Res., 98, 148, 10.1177/0022034518805739 · DOI · Paper page
  152. Omori, 2008, Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase, J. Leukoc. Biol., 84, 292, 10.1189/jlb.1207832 · DOI
  153. Wu, 2015, Diabetes mellitus related bone metabolism and periodontal disease, Int. J. Oral Sci., 7, 63, 10.1038/ijos.2015.2 · DOI
  154. Gasmi, 2021, Association between the gut and oral microbiome with obesity, Anaerobe, 70, 102248, 10.1016/j.anaerobe.2020.102248 · DOI
  155. Schamarek, 2023, The role of the oral microbiome in obesity and metabolic disease: Potential systemic implications and effects on taste perception, Nutr. J., 22, 28, 10.1186/s12937-023-00856-7 · DOI
  156. Scheithauer, T.P.M., Rampanelli, E., Nieuwdorp, M., Vallance, B.A., Verchere, C.B., Van Raalte, D.H., and Herrema, H. (2020). Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes. Front. Immunol., 11. · DOI
  157. Goodson, 2009, Is obesity an oral bacterial disease?, J. Dent. Res., 88, 519, 10.1177/0022034509338353 · DOI
  158. Cani, 2007, Metabolic Endotoxemia Initiates Obesity and Insulin Resistance, Diabetes, 56, 1761, 10.2337/db06-1491 · DOI · Paper page
  159. Janem, W.F., Scannapieco, F.A., Sabharwal, A., Tsompana, M., Berman, H.A., Haase, E.M., Miecznikowski, J.C., and Mastrandrea, L.D. (2017). Salivary inflammatory markers and microbiome in normoglycemic lean and obese children compared to obese children with type 2 diabetes. PLoS ONE, 12. · DOI
  160. Sohail, M.U., Elrayess, M.A., Al Thani, A.A., Al-Asmakh, M., and Yassine, H.M. (2019). Profiling the Oral Microbiome and Plasma Biochemistry of Obese Hyperglycemic Subjects in Qatar. Microorganisms, 7. · DOI
  161. Mathur, 2015, Obesity and the microbiome, Expert Rev. Gastroenterol. Hepatol., 9, 1087, 10.1586/17474124.2015.1051029 · DOI
  162. Endo, 2010, Experimental Periodontitis Induces Gene Expression of Proinflammatory Cytokines in Liver and White Adipose Tissues in Obesity, J. Periodontol., 81, 520, 10.1902/jop.2009.090574 · DOI
  163. Maitre, Y., Mahalli, R., Micheneau, P., Delpierre, A., Amador, G., and Denis, F. (2021). Evidence and Therapeutic Perspectives in the Relationship between the Oral Microbiome and Alzheimer’s Disease: A Systematic Review. Int. J. Environ. Res. Public Health, 18. · DOI
  164. Poole, 2013, Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue, J. Alzheimer’s Dis., 36, 665, 10.3233/JAD-121918 · DOI
  165. Miklossy, 2011, Emerging roles of pathogens in Alzheimer disease, Expert Rev. Mol. Med., 13, e30, 10.1017/S1462399411002006 · DOI
  166. Miklossy, 2011, Alzheimer’s disease—A neurospirochetosis. Analysis of the evidence following Koch’s and Hill’s criteria, J. Neuroinflamm., 8, 90, 10.1186/1742-2094-8-90 · DOI
  167. Riviere, 2002, Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer’s disease, Oral Microbiol. Immunol., 17, 113, 10.1046/j.0902-0055.2001.00100.x · DOI
  168. Bulgart, 2020, Microbial involvement in Alzheimer disease development and progression, Mol. Neurodegener., 15, 42, 10.1186/s13024-020-00378-4 · DOI · Paper page
  169. Weaver, 2020, Amyloid beta is an early responder cytokine and immunopeptide of the innate immune system, Alzheimers Dement. Transl. Res. Clin. Interv., 6, e12100, 10.1002/trc2.12100 · DOI
  170. Liu, 2024, Porphyromonas gingivalis and the pathogenesis of Alzheimer’s disease, Crit. Rev. Microbiol., 50, 127, 10.1080/1040841X.2022.2163613 · DOI
  171. Soscia, S.J., Kirby, J.E., Washicosky, K.J., Tucker, S.M., Ingelsson, M., Hyman, B., Burton, M.A., Goldstein, L.E., Duong, S., and Tanzi, R.E. (2010). The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS ONE, 5. · DOI · Paper page
  172. Bornschein, 2005, Prevalence and incidence of Parkinson’s disease in Europe, Eur. Neuropsychopharmacol., 15, 473, 10.1016/j.euroneuro.2005.04.007 · DOI
  173. Weintraub, 2008, Parkinson’s disease-—Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment, Am. J. Manag. Care, 14, S40
  174. Poewe, 2017, Parkinson disease, Nat. Rev. Dis. Primers, 3, 17013, 10.1038/nrdp.2017.13 · DOI · Paper page
  175. Adams, B., Nunes, J.M., Page, M.J., Roberts, T., Carr, J., Nell, T.A., Kell, D.B., and Pretorius, E. (2019). Parkinson’s Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens. Front. Aging Neurosci., 11. · DOI
  176. Chen, 2017, Periodontal inflammatory disease is associated with the risk of Parkinson’s disease: A population-based retrospective matched-cohort study, PeerJ, 5, e3647, 10.7717/peerj.3647 · DOI
  177. Jeong, E., Park, J.-B., and Park, Y.-G. (2021). Evaluation of the association between periodontitis and risk of Parkinson’s disease: A nationwide retrospective cohort study. Sci. Rep., 11. · DOI
  178. Pretorius, 2018, The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals with Alzheimer-Type Dementia, Front Aging Neurosci., 22, 257, 10.3389/fnagi.2018.00257 · DOI
  179. Huang, 2023, The oral microbiome in autoimmune diseases: Friend or foe?, J. Transl. Med., 21, 211, 10.1186/s12967-023-03995-x · DOI
  180. Bellando-Randone, S., Russo, E., Venerito, V., Matucci-Cerinic, M., Iannone, F., Tangaro, S., and Amedei, A. (2021). Exploring the Oral Microbiome in Rheumatic Diseases, State of Art and Future Prospective in Personalized Medicine with an AI Approach. J. Pers. Med., 11. · DOI
  181. Rosenstein, 2004, Hypothesis: The Humoral Immune Response to Oral Bacteria Provides a Stimulus for the Development of Rheumatoid Arthritis, Inflammation, 28, 311, 10.1007/s10753-004-6641-z · DOI
  182. Guo, 2018, Rheumatoid arthritis: Pathological mechanisms and modern pharmacologic therapies, Bone Res., 6, 15, 10.1038/s41413-018-0016-9 · DOI
  183. Zorba, 2020, The possible role of oral microbiome in autoimmunity, Int. J. Womens Dermatol., 6, 357, 10.1016/j.ijwd.2020.07.011 · DOI
  184. Marwaha, A.K., Leung, N.J., McMurchy, A.N., and Levings, M.K. (2012). TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?. Front. Immunol., 3. · DOI
  185. Moura, 2010, Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis, Arthritis Res. Ther., 12, R196, 10.1186/ar3168 · DOI
  186. Korman, 2020, Periodontal disease and influence of periodontal treatment on disease activity in patients with rheumatoid arthritis and spondyloarthritis, Rheumatol. Int., 40, 455, 10.1007/s00296-019-04460-z · DOI
  187. Konig, 2016, Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis, Sci. Transl. Med., 8, 369ra176, 10.1126/scitranslmed.aaj1921 · DOI
  188. Rooney, C.M., Mankia, K., and Emery, P. (2020). The Role of the Microbiome in Driving RA-Related Autoimmunity. Front. Cell Dev. Biol., 8. · DOI
  189. Gao, L., Cheng, Z., Zhu, F., Bi, C., Shi, Q., and Chen, X. (2022). The Oral Microbiome and Its Role in Systemic Autoimmune Diseases: A Systematic Review of Big Data Analysis. Front. Big Data, 5. · DOI
  190. Pessoa, L., Aleti, G., Choudhury, S., Nguyen, D., Yaskell, T., Zhang, Y., Li, W., Nelson, K.E., Neto, L.L.S., and Sant’Ana, A.C.P. (2019). Host-Microbial Interactions in Systemic Lupus Erythematosus and Periodontitis. Front. Immunol., 10. · DOI
  191. Liu, F., Ren, T., Li, X., Zhai, Q., Xu, X., Zhang, N., Jiang, P., Niu, Y., Lv, L., and Shi, G. (2021). Distinct Microbiomes of Gut and Saliva in Patients with Systemic Lupus Erythematous and Clinical Associations. Front. Immunol., 12. · DOI
  192. Clancy, 2020, Salivary dysbiosis and the clinical spectrum in anti-Ro positive mothers of children with neonatal lupus, J. Autoimmun., 107, 102354, 10.1016/j.jaut.2019.102354 · DOI
  193. Li, 2015, Interleukin-17 in systemic lupus erythematosus: A comprehensive review, Autoimmunity, 48, 353, 10.3109/08916934.2015.1037441 · DOI
  194. Cho, 2012, IL-33 induces Th17-mediated airway inflammation via mast cells in ovalbumin-challenged mice, Am. J. Physiol. Lung Cell Mol. Physiol., 302, L429, 10.1152/ajplung.00252.2011 · DOI
  195. Naka, 2002, The paradigm of IL-6: From basic science to medicine, Arthritis Res., 4, S233, 10.1186/ar565 · DOI
  196. Yamamura, 2019, Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res., 25, 6170, 10.1158/1078-0432.CCR-19-0318 · DOI
  197. Sun, 2020, Role of the oral microbiota in cancer evolution and progression, Cancer Med., 9, 6306, 10.1002/cam4.3206 · DOI
  198. Sarao, 2017, Probiotics, prebiotics, and microencapsulation: A review, Crit. Rev. Food Sci. Nutr., 57, 344, 10.1080/10408398.2014.887055 · DOI
  199. Jansen, P.M., Abdelbary, M.M.H., and Conrads, G. (2021). A concerted probiotic activity to inhibit periodontitis-associated bacteria. PLoS ONE, 16. · DOI
  200. Kaci, 2014, Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract, Appl. Environ. Microbiol., 80, 928, 10.1128/AEM.03133-13 · DOI

200 of 244 shown

Cited by

Sorted by citations

Metadata

Authors
Rajasekaran, J. J., Krishnamurthy, H. K., Bosco, J., Jayaraman, V., Krishna, K., Wang, T., & Bei, K.
Affiliations
  • Vibrant Sciences LLC, Santa Clara, CA 95054, USA
  • Vibrant America LLC, Santa Clara, CA 95054, USA
ORCID
Krishnamurthy, Hari Krishnan
Venue
Microorganisms
Publisher
MDPI AG
Published
2024-08-29
Volume
12
Issue
9
Pages
1797
ISSN
2076-2607
DOI
10.3390/microorganisms12091797
PMC
PMC11434369
Cited by
272
References
27
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
Vibrant America

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review